Literature DB >> 25417594

Melancholia and catatonia: disorders or specifiers?

Gordon Parker1, Georgia McClure, Amelia Paterson.   

Abstract

The fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 defines mental disorders as syndromes and also introduced disorder "specifiers" with the aim of providing increased diagnostic specificity by defining more homogeneous subgroups of those with the disorder and who share certain features. While the majority of specifiers in DSM-5 define a specific aspect of the disorder such as age at onset or severity, some define syndromes that appear to meet the DSM-5 definition of a mental disorder. Specifically, melancholia is positioned in DSM-5 as a major depressive disorder (non-coded) specifier, while catatonia is listed as both a disorder secondary to a medical condition and as a specifier associated with other mental disorders such as schizophrenia, major depressive disorder, and bipolar disorder. Despite decades of research supporting melancholia's status as a categorical "disorder" (a higher-order construct than a specifier), failure to provide convincing support for its disorder status has contributed to its current positioning in DSM-5. As DSM-5 has similar symptom criteria for major depression and for its melancholia specifier, research seeking to differentiate melancholic and non-melancholic depression according to DSM-5 criteria will have limited capacity to demonstrate "melancholia" as a separate disorder and risks melancholia continuing to be reified as a low-order specifier and thus clinical marginalization. There have been few advances in catatonia research in recent years with its positioning largely relying on opinion and clinical observation rather than on empirical studies.

Entities:  

Mesh:

Year:  2015        PMID: 25417594     DOI: 10.1007/s11920-014-0536-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  33 in total

1.  The interdependence of subtype and severity: contributions of clinical and neuropsychological features to melancholia and non-melancholia in an outpatient sample.

Authors:  Candice Quinn; Anthony Harris; Andrew Kemp
Journal:  J Int Neuropsychol Soc       Date:  2012-02-03       Impact factor: 2.892

2.  Clinical differences between melancholic and nonmelancholic depression as defined by the CORE system.

Authors:  Marco Antonio Knob Caldieraro; Fernanda Lucia Capitanio Baeza; Diesa Oliveira Pinheiro; Mariana Rangel Ribeiro; Gordon Parker; Marcelo P Fleck
Journal:  Compr Psychiatry       Date:  2012-07-06       Impact factor: 3.735

3.  Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression.

Authors:  Carles Soriano-Mas; Rosa Hernández-Ribas; Jesús Pujol; Mikel Urretavizcaya; Joan Deus; Ben J Harrison; Hector Ortiz; Marina López-Solà; Josep M Menchón; Narcís Cardoner
Journal:  Biol Psychiatry       Date:  2010-09-26       Impact factor: 13.382

4.  Melancholia: a distinct entity?

Authors:  Paul Grof
Journal:  Can J Psychiatry       Date:  2013-04       Impact factor: 4.356

5.  The two kinds of depression according to St. Paul.

Authors:  M D Altschule
Journal:  Br J Psychiatry       Date:  1967-07       Impact factor: 9.319

Review 6.  Catatonia: clinical aspects and neurobiological correlates.

Authors:  Jessica Daniels
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

7.  The impact of depression heterogeneity on inhibitory control.

Authors:  Candice R Quinn; Anthony Harris; Andrew H Kemp
Journal:  Aust N Z J Psychiatry       Date:  2012-01-05       Impact factor: 5.744

8.  The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: a 12-week single-blind randomized study.

Authors:  G Parker; B Blanch; A Paterson; D Hadzi-Pavlovic; E Sheppard; V Manicavasagar; H Synnott; R K Graham; P Friend; D Gilfillan; T Perich
Journal:  Acta Psychiatr Scand       Date:  2012-12-14       Impact factor: 6.392

9.  Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy.

Authors:  Ahmet Unal; Feridun Bulbul; Gokay Alpak; Osman Virit; U Sertan Copoglu; Haluk A Savas
Journal:  J ECT       Date:  2013-09       Impact factor: 3.635

10.  Validation of a new prototypic measure of melancholia.

Authors:  Gordon Parker; Stacey McCraw; Kathryn Fletcher; Paul Friend; Shulamit Futeran
Journal:  Compr Psychiatry       Date:  2013-04-18       Impact factor: 3.735

View more
  2 in total

Review 1.  Catatonia in autism spectrum disorders: A systematic review and meta-analysis.

Authors:  J Vaquerizo-Serrano; G Salazar De Pablo; J Singh; P Santosh
Journal:  Eur Psychiatry       Date:  2021-12-15       Impact factor: 5.361

2.  Enhancing Multi-Center Generalization of Machine Learning-Based Depression Diagnosis From Resting-State fMRI.

Authors:  Takashi Nakano; Masahiro Takamura; Naho Ichikawa; Go Okada; Yasumasa Okamoto; Makiko Yamada; Tetsuya Suhara; Shigeto Yamawaki; Junichiro Yoshimoto
Journal:  Front Psychiatry       Date:  2020-05-28       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.